Advertisement

ZAK Zürich pp 207-213 | Cite as

Die Intensivtherapie und Allgemeinanästhesie bei Präklampsie und Eklampsie

  • H. Schaer
Conference paper
  • 16 Downloads
Part of the Anaesthesiologie und Intensivmedizin Anaesthesiology and Intensive Care Medicine book series (A+I, volume 189)

Zusammenfassung

Die EPH-Gestose kann pathogenetisch eingeteilt werden in die Pfropfgestose mit vorbestehendem vaskulären oder renalen Leiden, in die essentielle EPH-Gestose, in die Gestose mit konkomitierender Erkrankung und schließlich in die unklassifizierte Gestose.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Barthel-Wottke G, Goecke C (1978) EPH-Gestose. Organisation Gestosis Press (Publ. Nr. 13)Google Scholar
  2. 2.
    Beecham JB, Watson WJ (1974) Eclampsia, preeclampsia, and disseminated intravascular coagulation. Obstet Gynecol 43/4:576–585PubMedGoogle Scholar
  3. 3.
    Berger M, Cavanagh D (1963) Toxemia of pregnancy. The hypertensive effect of acute experimental placental ischemia. Am J Obstet Gynecol 87:293–305PubMedGoogle Scholar
  4. 4.
    Bieniarz J et al (1968) Aortocaval compression by the uterus in late human pregnancy. II. An arteriographic study. Am J Obstet Gynecol 100:203–217Google Scholar
  5. 5.
    Blekta M, Hlavaty V et al (1970) Volume of whole blood and absolute amount of serum proteins in the early stage of late toxemia of pregnancy. Am J Obstet Gynecol 106:10–13PubMedGoogle Scholar
  6. 6.
    Brock-Utne JG, Downing JW, Seedat F (1977) Laryngeal oedema associated with pre-eclamptic toxaemia. Anaesthesia 32:556–558PubMedCrossRefGoogle Scholar
  7. 7.
    Cloeren SE, Lippert TH, Hinselmann M (1973) Hypovolemia in toxemia of pregnancy: Plasma expander therapy with surveillance of central venous pressure. Arch Gynakol 215:123–132PubMedCrossRefGoogle Scholar
  8. 8.
    Gau GS, Bhundia J et al (1983) The worm that wasn’t. Lancet 21:1160–1161CrossRefGoogle Scholar
  9. 9.
    Gille J (1981) Die Pathogenese der essentiellen EPH-Gestose. Organisation Gestosis Press (Publ. Nr. 18)Google Scholar
  10. 10.
    Goodlin RC (1976) Severe pre-eclampsia: Another great imitator. Am J Obstet Gynecol 125:747–753PubMedGoogle Scholar
  11. 11.
    Goodman LS, Gilman A (1970) The pharmacological basis of therapeutics. Maillan, London TorontoGoogle Scholar
  12. 12.
    Hibbard BM, Rosen M (1977) The management of severe pre-eclampsia and eclampsia. Br J Anaesth 49:3–9PubMedCrossRefGoogle Scholar
  13. 13.
    Hodgkinson R, Husain FJ et al (1980) Systemic and pulmonary blood pressure during caesarean section in parturients with gestational hypertension. Can Anaesth Soc J 27/4:389–394PubMedCrossRefGoogle Scholar
  14. 14.
    Jacobs MM, Knight AB et al (1980) Maternal pulmonary edema resulting from betamimetic and glucocorticoid therapy. Obstet Gynecol 56/1:56–59PubMedGoogle Scholar
  15. 15.
    Liggins GC, Howie RN (1972) A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50/4:515–525PubMedGoogle Scholar
  16. 16.
    Lueck J, Brewer JI et al (1983) Observation of an organism found in patients with gestational trophoblastic disease and in patients with toxemia of pregnancy. Am J Obstet Gynecol 145:15–26PubMedGoogle Scholar
  17. 17.
    Marti JJ, Herrmann U (1977) Immunogestosis: A new etiologic concept of „essential“ EPH gestosis, with special consideration of the primigravid patient. Am J Obstet Gynecol 128:489–493PubMedGoogle Scholar
  18. 18.
    Martin JT (1970) Neuroanesthetic adjuncts for patients in the sitting position. Ill Intravascular electrocardiography. Anesth Analg 49:793–808PubMedGoogle Scholar
  19. 19.
    Marx Gertie F (1974) Aortocaval compression: Incidence and prevention. Bull NY Acad Med 50/4: 443–446Google Scholar
  20. 20.
    Mashiach S et al (1979) The effect of intraamniotic thyroxine administration on fetal lung maturity in man J Perinat Med 7:161–170Google Scholar
  21. 21.
    Moir DD, Amoa AB (1979) Ergometrine or oxytocin? Br J Anaesth 51:113–117PubMedCrossRefGoogle Scholar
  22. 22.
    Pritchard JA (1980) Management of preeclampsia and eclampsia. Kidney Int 18:259–266PubMedCrossRefGoogle Scholar
  23. 23.
    Scott JS, Jenkins DM (1976) Immunogenetic factors in aetiology of pre-eclampsia/eclampsia (gestosis) J Med Genet 13:200–207PubMedGoogle Scholar
  24. 24.
    Secher NJ, Arnsbo P et al (1978) Haemodynamic effects of oxytocin (syntocinon) and methyl ergometrine (methergin) on the systemic and pulmonary circulations of pregnant anaesthetized women. Acta Obstet Gynecol Scand 57/2:97–103PubMedCrossRefGoogle Scholar
  25. 25.
    Sidiropoulos D et al (im Druck) Zur Prophylaxe der hyaline Membranen-Krankheit durch intraamniale Thyroxingabe. Gynakol RundschauGoogle Scholar
  26. 26.
    Söder G, Grenroth C et al (1975) Treatment of pre-eclampsia and eclampsia as a hypoperfusion syndrome. Acta Anaesth Scand [Suppl] 57:71–78CrossRefGoogle Scholar
  27. 27.
    Symonds EM (1980) Aetiology of pre-eclampsia: A review. J R Soc Med 73:871–875PubMedGoogle Scholar
  28. 28.
    Symonds EM (1980) The treatment of pre-eclampsia. Acta Obstet Gynecol Scand [Suppl] 93:9–16CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • H. Schaer

There are no affiliations available

Personalised recommendations